Cargando…

PET/CT and Conventional Imaging for the Assessment of Neuroendocrine Prostate Cancer: A Systematic Review

SIMPLE SUMMARY: Neuroendocrine prostate cancer is a rare neoplasm with aggressive behavior and poor prognosis. Its diagnostic approach is challenging since no specific features are present when using conventional imaging or positron emission tomography (PET). The aim of this systematic review was, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Dondi, Francesco, Antonelli, Alessandro, Suardi, Nazareno, Guerini, Andrea Emanuele, Albano, Domenico, Lucchini, Silvia, Camoni, Luca, Treglia, Giorgio, Bertagna, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486674/
https://www.ncbi.nlm.nih.gov/pubmed/37686680
http://dx.doi.org/10.3390/cancers15174404
_version_ 1785103062618079232
author Dondi, Francesco
Antonelli, Alessandro
Suardi, Nazareno
Guerini, Andrea Emanuele
Albano, Domenico
Lucchini, Silvia
Camoni, Luca
Treglia, Giorgio
Bertagna, Francesco
author_facet Dondi, Francesco
Antonelli, Alessandro
Suardi, Nazareno
Guerini, Andrea Emanuele
Albano, Domenico
Lucchini, Silvia
Camoni, Luca
Treglia, Giorgio
Bertagna, Francesco
author_sort Dondi, Francesco
collection PubMed
description SIMPLE SUMMARY: Neuroendocrine prostate cancer is a rare neoplasm with aggressive behavior and poor prognosis. Its diagnostic approach is challenging since no specific features are present when using conventional imaging or positron emission tomography (PET). The aim of this systematic review was, therefore, to evaluate the role of these imaging modalities for the assessment of neuroendocrine prostate cancer. At present, it is still uncertain which tracer performs best, and although [(18)F]FDG has been evaluated and seems to offer some advantages in availability and clinical staging, other tracers may be more useful to understand tumor biology or identify targets for subsequent radioligand therapy. Further research is therefore desirable. In contrast, data are still limited to draw a final conclusion on the role and the specific characteristics of CI in this rare form of neoplasm, and therefore, more studies are needed in this setting. ABSTRACT: Background: Neuroendocrine prostate cancer (NEPC) is a rare neoplasm, and the role of both conventional imaging (CI) and positron emission tomography/computed tomography (PET/CT) for its assessment has not been clearly evaluated and demonstrated. The aim of this systematic review was to analyze the diagnostic performances of these imaging modalities in this setting. Methods: A wide literature search of the PubMed/MEDLINE, Scopus, and Web of Science databases was made to find relevant published articles about the role of CI and PET/CT for the evaluation of NEPC. Results: 13 studies were included in the systematic review. PET/CT imaging with different radiopharmaceuticals has been evaluated in many studies (10) compared to CI (3 studies), which has only a limited role in NEPC. Focusing on PET/CT, a study used [(18)F]FDG, labeled somatostatin analogs were used in 5 cases, a study used [(68)Ga]Ga-FAPI-04, [(68)Ga]Ga-PSMA-11 was evaluated in a single case, and two works used different tracers. Conclusion: Published data on the role of PET/CT for the assessment of NEPC are limited. At present, it is still uncertain which tracer performs best, and although [(18)F]FDG has been evaluated and seems to offer some advantages in availability and clinical staging, other tracers may be more useful to understand tumor biology or identify targets for subsequent radioligand therapy. Further research is therefore desirable. In contrast, data are still limited to draw a final conclusion on the role and the specific characteristics of CI in this rare form of neoplasm, and therefore, more studies are needed in this setting.
format Online
Article
Text
id pubmed-10486674
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104866742023-09-09 PET/CT and Conventional Imaging for the Assessment of Neuroendocrine Prostate Cancer: A Systematic Review Dondi, Francesco Antonelli, Alessandro Suardi, Nazareno Guerini, Andrea Emanuele Albano, Domenico Lucchini, Silvia Camoni, Luca Treglia, Giorgio Bertagna, Francesco Cancers (Basel) Review SIMPLE SUMMARY: Neuroendocrine prostate cancer is a rare neoplasm with aggressive behavior and poor prognosis. Its diagnostic approach is challenging since no specific features are present when using conventional imaging or positron emission tomography (PET). The aim of this systematic review was, therefore, to evaluate the role of these imaging modalities for the assessment of neuroendocrine prostate cancer. At present, it is still uncertain which tracer performs best, and although [(18)F]FDG has been evaluated and seems to offer some advantages in availability and clinical staging, other tracers may be more useful to understand tumor biology or identify targets for subsequent radioligand therapy. Further research is therefore desirable. In contrast, data are still limited to draw a final conclusion on the role and the specific characteristics of CI in this rare form of neoplasm, and therefore, more studies are needed in this setting. ABSTRACT: Background: Neuroendocrine prostate cancer (NEPC) is a rare neoplasm, and the role of both conventional imaging (CI) and positron emission tomography/computed tomography (PET/CT) for its assessment has not been clearly evaluated and demonstrated. The aim of this systematic review was to analyze the diagnostic performances of these imaging modalities in this setting. Methods: A wide literature search of the PubMed/MEDLINE, Scopus, and Web of Science databases was made to find relevant published articles about the role of CI and PET/CT for the evaluation of NEPC. Results: 13 studies were included in the systematic review. PET/CT imaging with different radiopharmaceuticals has been evaluated in many studies (10) compared to CI (3 studies), which has only a limited role in NEPC. Focusing on PET/CT, a study used [(18)F]FDG, labeled somatostatin analogs were used in 5 cases, a study used [(68)Ga]Ga-FAPI-04, [(68)Ga]Ga-PSMA-11 was evaluated in a single case, and two works used different tracers. Conclusion: Published data on the role of PET/CT for the assessment of NEPC are limited. At present, it is still uncertain which tracer performs best, and although [(18)F]FDG has been evaluated and seems to offer some advantages in availability and clinical staging, other tracers may be more useful to understand tumor biology or identify targets for subsequent radioligand therapy. Further research is therefore desirable. In contrast, data are still limited to draw a final conclusion on the role and the specific characteristics of CI in this rare form of neoplasm, and therefore, more studies are needed in this setting. MDPI 2023-09-03 /pmc/articles/PMC10486674/ /pubmed/37686680 http://dx.doi.org/10.3390/cancers15174404 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Dondi, Francesco
Antonelli, Alessandro
Suardi, Nazareno
Guerini, Andrea Emanuele
Albano, Domenico
Lucchini, Silvia
Camoni, Luca
Treglia, Giorgio
Bertagna, Francesco
PET/CT and Conventional Imaging for the Assessment of Neuroendocrine Prostate Cancer: A Systematic Review
title PET/CT and Conventional Imaging for the Assessment of Neuroendocrine Prostate Cancer: A Systematic Review
title_full PET/CT and Conventional Imaging for the Assessment of Neuroendocrine Prostate Cancer: A Systematic Review
title_fullStr PET/CT and Conventional Imaging for the Assessment of Neuroendocrine Prostate Cancer: A Systematic Review
title_full_unstemmed PET/CT and Conventional Imaging for the Assessment of Neuroendocrine Prostate Cancer: A Systematic Review
title_short PET/CT and Conventional Imaging for the Assessment of Neuroendocrine Prostate Cancer: A Systematic Review
title_sort pet/ct and conventional imaging for the assessment of neuroendocrine prostate cancer: a systematic review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486674/
https://www.ncbi.nlm.nih.gov/pubmed/37686680
http://dx.doi.org/10.3390/cancers15174404
work_keys_str_mv AT dondifrancesco petctandconventionalimagingfortheassessmentofneuroendocrineprostatecancerasystematicreview
AT antonellialessandro petctandconventionalimagingfortheassessmentofneuroendocrineprostatecancerasystematicreview
AT suardinazareno petctandconventionalimagingfortheassessmentofneuroendocrineprostatecancerasystematicreview
AT gueriniandreaemanuele petctandconventionalimagingfortheassessmentofneuroendocrineprostatecancerasystematicreview
AT albanodomenico petctandconventionalimagingfortheassessmentofneuroendocrineprostatecancerasystematicreview
AT lucchinisilvia petctandconventionalimagingfortheassessmentofneuroendocrineprostatecancerasystematicreview
AT camoniluca petctandconventionalimagingfortheassessmentofneuroendocrineprostatecancerasystematicreview
AT tregliagiorgio petctandconventionalimagingfortheassessmentofneuroendocrineprostatecancerasystematicreview
AT bertagnafrancesco petctandconventionalimagingfortheassessmentofneuroendocrineprostatecancerasystematicreview